Tuesday, April 26, 2016

BRIEF-AstraZeneca, Ironwood agree U.S. licensing agreement

* Agreement includes U.S. rights to zurampic and

lesinurad/allopurinol fixed-dose combination in gout

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)